Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial. - Surrey,E.S.; Judd,H.L. (J Clin Endocrinol Metab, 1992)